Abstract
Objectives Scabies is a neglected skin disease that disproportionately affects people from resource poor and overcrowded countries. Global data on prevalence and risk factors are limited. This article aims to estimate the global burden of scabies and identifies the risks associated with it.
Methods Databases (PubMed, Scopus and Cochrane Reviews) were accessed to identify studies of scabies prevalence published between 2000 and 2024. Results were pooled to estimate prevalence and identify factors which explained between-study heterogeneity. Odds ratios, risk of bias, subgroup analyses and meta-regression were used to describe variation in effect size and heterogeneity based on country-level demographic and economic variables.
Results Seventy studies yielded a pooled prevalence of 11.9% (95% confidence interval [CI] 9.60%-14.7%) with substantial heterogeneity (12 = 100%; r2 = 1.04). Prevalence was highest in Oceania (17.9%; 95% CI 13.9-22.8) compared to other regions. Pooled risk factors for scabies showed significant associations for demographic and behavioral factors including contact history with household members with itch (odds ratio [OR] 11.3; 95% CI 4.82-26.51; 12 = 96%; n = 7), lack of soap use (OR 3.41; 95% CI 2.56-4.54; 12 = 44%; n = 7), bed-sharing (OR 2.64; 95% CI 1.50-4.63; 12 = 76%; n = 7), sharing of clothes (OR 2.52; 95% CI 1.58-4.03; 12 = 85%; n = 7), infrequent bathing (OR 2.13; 95% CI 1.41-3.22; 12 = 77%; n = 6), presence of pets (OR 1.76; 95% CI 1.08-2.87; 12 = 84%; n = 4) and being a male (OR = 1.19; 95% CI 1.04-1.37; 12 = 83%; n = 22). Socio-economic factors were not convincingly associated with scabies prevalence.
Conclusion Prevalence of scabies is associated with geographic location and behavioural factors, but not between-country socioeconomic status. In addition to mass drug administration, risk factors are identified which may be included in health promotion programmes to reduce scabies prevalence and its sequelae in the long term.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
16 new studies were included to update the pooled results. Some studies were missed out from the search criteria in the previous version while the rest were published recently. The search criteria have been updated and made more exclusive.
Data Availability
All data produced in the present work are contained in the manuscript
